和铂医药-B(02142)公布首款候选药物用于肥胖症治疗的下一代靶向ACVR2A/2B抗体LET003的临床前数据
Last Update:
18 5 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.